CGC Stock Analysis: Buy, Sell, or Hold?
CGC - Canopy Growth Corporation Common Shares
$1.04
-0.04 (-3.70%)
▼
5d:
-8.77%
30d:
-11.11%
90d:
-6.31%
HOLD
MODERATE Confidence
Analysis Updated: Mar 5, 2026 12:00 AM ET
Earnings: May 29, 2026
Smart Money Accumulation
CGC is down 7.7% this week, but smart money is accumulating calls. Top strike: $1.5 2026-04-17 with 20,115 OI. Call ratio: 66% View Scanner →
Strength: 5.5/10
Get Alerted When CGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called CGC this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CGC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CGC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: CGC is currently trading at $1.04, which is considered oversold relative to its 30-day fair value range of $1.07 to $1.16. From a valuation perspective, the stock is trading at a discount (Forward PE: -10.8) compared to its historical average (13.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CGC is in a downtrend. The price is currently testing key support at $1.04. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: CGC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.79 (+66.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CGC is in a downtrend. The price is currently testing key support at $1.04. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: CGC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.79 (+66.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.07 -
$1.16
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding CGC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 66.1% below Wall St target ($1.79)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: 5-day price weakness (-8.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.07 -
$1.16
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.04
Resistance Level
$1.22
Current Trend
Downtrend
Technical data as of
Mar 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.80
Wall Street Target
$1.79
(+66.1%)
Revenue Growth (YoY)
-0.3%
Profit Margin
-117.3%
PE vs Historical
-10.8 vs 13.0
CHEAP
Share & Embed Analysis
Last updated: March 06, 2026 5:47 AM ET
Data refreshes hourly during market hours. Next update: 6:47 AM
Data refreshes hourly during market hours. Next update: 6:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Luc Mongeau
SELL
9376 shares
2026-02-11
Theresa Yanofsky
SELL
10434 shares
2025-12-31
M Shan Atkins
SELL
2216 shares
2025-09-29
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$177 | 59 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$85 | 67 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 56 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$38 | 58 HOLD |
Advanced CGC Option Strategies
Professional options setups generated by AI based on today's CGC price and gamma walls.
